z-logo
Premium
Vibrational biospectroscopy coupled with multivariate analysis extracts potentially diagnostic features in blood plasma/serum of ovarian cancer patients
Author(s) -
Owens Gemma L.,
Gajjar Ketan,
Trevisan Júlio,
Fogarty Simon W.,
Taylor Siân E.,
Da GamaRose Bianca,
MartinHirsch Pierre L.,
Martin Francis L.
Publication year - 2014
Publication title -
journal of biophotonics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.877
H-Index - 66
eISSN - 1864-0648
pISSN - 1864-063X
DOI - 10.1002/jbio.201300157
Subject(s) - ovarian cancer , raman spectroscopy , principal component analysis , medicine , blood plasma , cancer , gastroenterology , chemistry , artificial intelligence , physics , computer science , optics
Despite numerous advances in “omics” research, early detection of ovarian cancer still remains a challenge. The aim of this study was to determine whether attenuated total reflection Fourier‐transform infrared (ATR‐FTIR) or Raman spectroscopy could characterise alterations in the biomolecular signatures of human blood plasma/serum obtained from ovarian cancer patients compared to non‐cancer controls. Blood samples isolated from ovarian cancer patients ( n = 30) and healthy controls ( n = 30) were analysed using ATR‐FTIR spectroscopy. For comparison, a smaller cohort of samples ( n = 8) were analysed using an InVia Renishaw Raman spectrometer. Resultant spectra were pre‐processed prior to being inputted into principal component analysis (PCA) and linear discriminant analysis (LDA). Statistically significant differences ( P < 0.001) were observed between spectra of ovarian cancer versus control subjects for both biospectroscopy methods. Using a support vector machine classifier for Raman spectra of blood plasma, a diagnostic accuracy of 74% was achieved, while the same classifier showed 93.3% accuracy for IR spectra of blood plasma. These observations suggest that a biospectroscopy approach could be applied to identify spectral alterations associated with the presence of insidious ovarian cancer. (© 2014 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom